Lipoblastoma phenotype contains a somatic PIK3CA mutation.

Sudduth, Christopher L; Konczyk, Dennis J; Al-Ibraheemi, Alyaa; Smits, Patrick J; Greene, Arin K

Sudduth, Christopher L; Konczyk, Dennis J; Al-Ibraheemi, Alyaa; Smits, Patrick J; Greene, Arin K.

Afiliación

Sudduth CL; Department of Plastic and Oral Surgery, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA.
Konczyk DJ; Department of Plastic and Oral Surgery, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA.
Al-Ibraheemi A; Department of Pathology, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA.
Smits PJ; Department of Plastic and Oral Surgery, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA.
Greene AK; Department of Plastic and Oral Surgery, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA.

Pediatr Dermatol ; 38(1): 299-300, 2021 Jan.

Article en En | MEDLINE | ID: mdl-33034408

Asunto(s)

Fosfatidilinositol 3-Quinasa Clase I; Lipoblastoma; Fosfatidilinositol 3-Quinasa Clase I/genética; Humanos; Lipoblastoma/diagnóstico; Lipoblastoma/genética; Mutación; Fenotipo

Palabras clave

PIK3CA; PROS; lipoblastoma; lipoma; overgrowth

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fosfatidilinositol 3-Quinasa Clase I / Lipoblastoma Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Pediatr Dermatol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google